Public Disclosures
Max Life Insurance has progressed well on all business parameters in the Financial Year 2021-22 and has further strengthened its position due to its continued focus on building a successful life insurance business to deliver the core value of long-term savings and protection.
- Gross written premium of the company grew 18% to Rs. 22,414 crore.
- Shareholders profit after tax at Rs. 387 crore.
- Assets under management increased by 19% to Rs. 107,510 crore.
- Solvency ratio of 201%, 1.34 times more than the mandatory 150% indicating the company’s strong and stable financial position.
- Conservation ratio at 85% and 13th month persistency at 85%.
- Policyholder Bonus Paid at Rs. 1,181 crore.
- Sum assured in force at Rs. 1,174,515 crore, recorded an increase of 8% over the previous financial year.
- Expenses of management to gross direct premium ratio stood at 20%.
- Grievance incidence rate was 40 per 10,000 policies for the year.
- We have paid 99.34% claims on individual business policies and 99.41% claims on group business policies.
Select by year
|
|
|
Public Disclosures | L1--L45 | Download |
For Agents : Agents listing
For Corporate Agents : Corporate Agent listing
Stewardship Code for Max Life Insurance
- Summary of Voting Actions during Quarter 1, April-June 2022.
- Summary of Voting Actions during Quarter 4, Jan-Mar 2022
- Summary of Voting Actions during Quarter 3, Oct-Dec 2021
- Stewardship Code for Max Life Insurance
- Summary of Voting Actions during Quarter 2, Jul-Sep 2021
- Summary of Voting Actions during Quarter 1, Apr-Jun 2021
- Summary of Voting Actions during Quarter 4, Jan-Mar 2021
- Summary of Voting Actions during Quarter 3, Oct-Dec 2020
- Summary of Voting Actions during Quarter 2, July-Sep 2020
- Summary of Voting Actions during Quarter 1, Apr-June 2020
- Summary of Voting Actions during Quarter 4, Jan-Mar 2020
- Summary of Voting Actions during Quarter 3, Oct-Dec 2019
- Summary of Voting Actions during Quarter 2, July-Sept 2019
- Summary of Voting Actions during Quarter 1, April-June 2019
- Summary of Voting actions during Quarter 4, Jan-Mar 2019
- Summary of Voting actions during Quarter 3, Oct-Dec 2018
- Summary of Voting Actions during Quarter 2, July-Sept 2018
- Summary of Voting Actions during Quarter 1, April-June 2018
- Summary of Voting Actions during Quarter 4, Jan-Mar 2018
- Summary of Voting Actions during Quarter 3, Oct-Dec 2017
- Summary of Voting Actions during Quarter 2, July-Sept 2017
Disclosures as a debt listed company
- QuarterlyAuditedFinancialResults_QE30June2022_MaxLife
- Notice of 102nd Statutory Board Meeting_Aug 1, 2022_Max Life
- SubmissionToNSE_Para2_ChapterXIVofNCSoperationalframework_MaxLife
- IntimationToNSE_Reg50_SEBILODR_MaxLife_June2022
- DisclosureUnderReg6and7oftheSEBILODRMaxLife_QE_june30_2022
- StatementOfInvestorGrievances_MaxLife_June302022
- IntimationtoNSEunderRegulation60(2)ofSEBILODR_MaxLife
- IntimationtoNSEunderRegulation57(4)OfSEBILODR_MaxLife
- NewspaperPublicationOfQ4AndFY22Results_MaxLife
- Notice for the 101st Statutory Board Meeting_May 10, 2022_Max Life
- AssetCoverUnder54_MaxLife
- AuditedFinancialResults_March312022_MaxLife_SEBILODR
- AnnualReport_Reg53(2)_SEBILODR_MaxLife_10May2022
- IntimationToNSE_Reg51(2)_SEBILODR_MaxLife_May2022
- IntimationToNSE_Reg50(1)_SEBILODR_MaxLife_May2022
- IntimationToNSE_Reg50(2)_SEBILODR_MaxLife_May2022
- Initial Disclosure to NSE_LC_SEBI circular dated Nov 26, 2018
- Compliance Certificate Under Clause7(3)ofSEBILODR_MaxLife
- Disclosure Under Reg6and7 of the SEBILODR_MaxLife
- StatementOfInvestorGrievances_Max Life_March312022
- StatementUnderSEBINCSOperationCircularMaxLifeMarch312022
- IntimationtoNSEForResignationofDyChiefFinancialOfficerMaxLife
- Intimation to NSE_Para 9.1 of Chapter XI of NCS operational framework_Ma
- Intimation To NSE_Reg50 SEBI LODR MaxLife January 28-01-2022
- Quarterly Financial Results December-31-2021 MaxLife
- Newspaper Publication Of Q3 FY22 Results MaxLife
- Intimation to NSE Regarding Reg6and7 of SEBI LODR MaxLife December-2021
- Notice for the 100th Board Meeting Jan 28 2022 Approval of Financials QE Dec 2021
- Statement of Investor Grievances MaxLife December 31 2021
- Notice of 99th Board Meeting - Nov 9, 2021 - Approval of Financials QE Sept, 2021
- Certificate on Asset Coverage Ratio_September 30, 2021
- Intimation to NSE_Reg 6 and 7_SEBI LODR_MaxLife
- Intimation to NSE_Reg50_SEBI LODR_MaxLife_Nov 2, 2021
- Newspaper publication of Q2FY22 Results_MaxLife
- Statement for Utilisation of Proceeds_MaxLife_Sept 30, 2021
- Statement of Investor grievances_MaxLife_Sept 30, 2021
- Statement under SEBI circular dated August 10, 2021